Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by DryBoneson Apr 14, 2018 1:26am
238 Views
Post# 27884202

Turf management. You have a vote.

Turf management. You have a vote.I was a shareholder of PLI at $2.00, about a decade before the stock dipped to about 9 cents.  Later on I had shares in Paladin at about $2.00  per share and sold those at $6.00.  That stock went to $48.00 under the direction of (I thinK)  Ned Goodman.  Paladin never had anything much, but acquired rights to fairly mundane pharmacueticals and took them to market.

WE need a Goodman here, literally speaking, not amateur businessmen at this stage.   
Bullboard Posts